Sugarloaf Wealth Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-13
| Closed | -$2.55K | – | 690 |
|
2023
Q3 | $2.55K | Sell |
13
-843
| -98% | -$165K | ﹤0.01% | 588 |
|
2023
Q2 | $180K | Buy |
856
+402
| +89% | +$84.5K | 0.04% | 148 |
|
2023
Q1 | $91.7K | Buy |
454
+160
| +54% | +$32.3K | 0.02% | 207 |
|
2022
Q4 | $64K | Sell |
294
-10
| -3% | -$2.18K | 0.02% | 249 |
|
2022
Q3 | $60K | Buy |
304
+19
| +7% | +$3.75K | 0.02% | 260 |
|
2022
Q2 | $61K | Buy |
285
+72
| +34% | +$15.4K | 0.02% | 251 |
|
2022
Q1 | $60K | Buy |
213
+59
| +38% | +$16.6K | 0.01% | 251 |
|
2021
Q4 | $58K | Buy |
154
+98
| +175% | +$36.9K | 0.01% | 267 |
|
2021
Q3 | $23K | Buy |
+56
| New | +$23K | 0.01% | 393 |
|